Literature DB >> 7518558

Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking.

Y Kawakami1, L Yao, T Miura, S Tsukada, O N Witte, T Kawakami.   

Abstract

Tyrosine phosphorylation of several cellular proteins is one of the earliest signaling events induced by cross-linking of the high-affinity receptor for immunoglobulin E (Fc epsilon RI) on mast cells or basophils. Tyrosine kinases activated during this process include the Src family kinases, Lyn, c-Yes, and c-Src, and members of another subfamily, Syk and PTK72 (identical or highly related to Syk). Recently, some of us described two novel tyrosine kinases, Emb and Emt, whose expression was limited to subsets of hematopoietic cells, including mast cells. Emb turned out to be identical to Btk, a gene product defective in human X-linked agammaglobulinemia and in X-linked immunodeficient (xid) mice. Here we report that Fc epsilon RI cross-linking induced rapid phosphorylation on tyrosine, serine, and threonine residues and activation of Btk in mouse bone marrow-derived mast cells. A small fraction of Btk translocated from the cytosol to the membrane compartment following receptor cross-linking. Tyrosine phosphorylation of Btk was not induced by either a Ca2+ ionophore (A23187), phorbol 12-myristate 13-acetate, or a combination of the two reagents. Co-immunoprecipitation between Btk and receptor subunit beta or gamma was not detected. The data collectively suggest that Btk is not associated with Fc epsilon but that its activation takes place prior to protein kinase C activation and plays a novel role in the Fc epsilon RI signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518558      PMCID: PMC359029          DOI: 10.1128/mcb.14.8.5108-5113.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  High-affinity IgE receptor-mediated stimulation of rat basophilic leukemia (RBL-2H3) cells induces early and late protein-tyrosine phosphorylations.

Authors:  M Benhamou; V Stephan; K C Robbins; R P Siraganian
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

Review 2.  Molecular approaches to analysis of X-linked immunodeficiencies.

Authors:  M E Conley
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

3.  Isolation of subcellular organelles.

Authors:  B Storrie; E A Madden
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 4.  Activation of mast cells for mediator release through IgE receptors.

Authors:  T Ishizaka; K Ishizaka
Journal:  Prog Allergy       Date:  1984

5.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Differential inhibition of the T cell activation pathway by dexamethasone and cyclosporine.

Authors:  M Furue; Y Kawakami; T Kawakami; S I Katz
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

7.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases.

Authors:  R H Chen; C Sarnecki; J Blenis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Fc epsilon R1-mediated tyrosine phosphorylation of multiple proteins, including phospholipase C gamma 1 and the receptor beta gamma 2 complex, in RBL-2H3 rat basophilic leukemia cells.

Authors:  W Li; G G Deanin; B Margolis; J Schlessinger; J M Oliver
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

9.  Tyrosine phosphorylation of phospholipase C gamma 1 couples the Fc epsilon receptor mediated signal to mast cells secretion.

Authors:  H Schneider; A Cohen-Dayag; I Pecht
Journal:  Int Immunol       Date:  1992-04       Impact factor: 4.823

10.  Stimulation of connective tissue-type mast cell proliferation by crosslinking of cell-bound IgE.

Authors:  M Takagi; T Nakahata; K Koike; T Kobayashi; K Tsuji; S Kojima; T Hirano; A Miyajima; K Arai; T Akabane
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  52 in total

1.  Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.

Authors:  H B Gaspar; M Ferrando; I Caragol; M Hernandez; J M Bertran; X De Gracia; T Lester; C Kinnon; E Ashton; T Espanol
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

3.  Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.

Authors:  Y Kawakami; S E Hartman; E Kinoshita; H Suzuki; J Kitaura; L Yao; N Inagaki; A Franco; D Hata; M Maeda-Yamamoto; H Fukamachi; H Nagai; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases.

Authors:  J Debnath; M Chamorro; M J Czar; E M Schaeffer; M J Lenardo; H E Varmus; P L Schwartzberg
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.

Authors:  O Parolini; J Rohrer; L H Shapiro; M E Conley
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation.

Authors:  M Huber; C D Helgason; J E Damen; L Liu; R K Humphries; G Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 8.  Signal transduction and chemotaxis in mast cells.

Authors:  Petr Draber; Ivana Halova; Iva Polakovicova; Toshiaki Kawakami
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

Review 9.  BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.

Authors:  M Spaargaren; M F M de Rooij; A P Kater; E Eldering
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

Review 10.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.